Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.905 SEK | -2.35% | -0.34% | -62.08% |
04-15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
04-04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.08% | 58.65M | |
+2.97% | 108B | |
+10.21% | 104B | |
+3.09% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides to Assess US FDA's Withdrawal of Blood Cancer Drug Approval